Skip to main content

Viatris Inc Generics revenue

  • VTRS · Nasdaq
  • Pharmaceuticals
  • S&P 500
$20.82+0.73%Close 13 Nov 2026

Generics revenue at Viatris Inc came to $1.3B for the quarter to 30 Sep 2026, down 2.9% from a year earlier.

As Viatris Inc reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 5 Nov 2026.

By quarter

$1.4BDec 2023$1.3BMar 2024$1.4BJun 2024$1.4BSep 2024$1.3BDec 2024$1.1BMar 2025$1.3BJun 2025$1.3BSep 2025$1.3BDec 2025$1.2BMar 2026$1.3BJun 2026$1.3BSep 2026
Viatris Inc Generics revenue, every reported period
Period endingGenerics revenueChange on a yearFiled
30 Sep 2026$1.3Bdown 2.9%5 Nov 2026
30 Jun 2026$1.3Bup 3.3%6 Aug 2026
31 Mar 2026$1.2Bup 4.5%7 May 2026
31 Dec 2025$1.3Bdown 0.3%26 Feb 2026
30 Sep 2025$1.3Bdown 4.7%6 Nov 2025
30 Jun 2025$1.3Bdown 9.7%7 Aug 2025
31 Mar 2025$1.1Bdown 16.2%8 May 2025
31 Dec 2024$1.3Bdown 5.2%27 Feb 2025
30 Sep 2024$1.4Bdown 1.8%7 Nov 2024
30 Jun 2024$1.4Bdown 2.9%8 Aug 2024
31 Mar 2024$1.3Bup 3.5%9 May 2024
31 Dec 2023$1.4Bup 8.9%28 Feb 2024
30 Sep 2023$1.4Bup 16.1%8 Nov 2023
30 Jun 2023$1.5Bup 15.6%7 Aug 2023
31 Mar 2023$1.3Bup 5.3%8 May 2023
31 Dec 2022$1.3Bdown 4.6%27 Feb 2023
30 Sep 2022$1.2Bdown 12.9%7 Nov 2022
30 Jun 2022$1.3Bdown 17.0%8 Aug 2022
31 Mar 2022$1.2Bdown 8.4%9 May 2022
31 Dec 2021$1.4Bdown 1.4%28 Feb 2022
30 Sep 2021$1.4Bup 2.3%8 Nov 2021
30 Jun 2021$1.5Bup 20.1%9 Aug 2021
31 Mar 2021$1.3Bup 5.7%10 May 2021
31 Dec 2020$1.4B—1 Mar 2021
30 Sep 2020$1.4B—10 Nov 2020
30 Jun 2020$1.3B—12 Aug 2020
31 Mar 2020$1.3B—12 May 2020

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Viatris Inc: Brands revenue · Lipitor revenue · Norvasc revenue · EpiPen® Auto-Injectors revenue · Lyrica ® revenue · Creon ® revenue · Viagra ® revenue · Influvac ® revenue · Zoloft ® revenue · Yupelri ® revenue · Celebrex ® revenue · Effexor ® revenue · Xalabrands revenue · Xanax ® revenue · Amitiza ® revenue · Dymista ® revenue · Developed Markets Segment revenue · Greater China revenue · Emerging Markets Segment revenue · Japan, Australia and New Zealand Segment revenue · financial statements

Every KPI and segment of VTRS, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.